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Abstract 
The relationship between facial shape and attractiveness has been extensively studied, yet few 
studies have investigated the underlying biological factors of an attractive face. Many 
researchers have proposed a link between female attractiveness and sex hormones, but there is 
little empirical evidence in support this assumption. In the present study we investigated the 
relationship between circulating sex hormones and attractiveness. We created prototypes by 
separately averaging photographs of 15 women with high and low levels of testosterone, 
estradiol, and testosterone-to-estradiol ratio levels, respectively. An independent set of facial 
images was then shape transformed toward these prototypes. We paired the resulting images in 
such a way that one face depicted a female with high hormone level and the other a low hormone 
level. Fifty participants were asked to choose the more attractive face of each pair. We found that 
low testosterone-to-estradiol ratio and low testosterone were positively associated with female 
facial attractiveness. There was no preference for faces with high estradiol levels. In an 
additional experiment with 36 participants we confirmed that a low testosterone-to-estradiol ratio 
plays a larger role than low testosterone alone. These results provide empirical evidence that an 
attractive female face is shaped by interacting effects of testosterone and estradiol. 
Keywords: facial attractiveness, face structure, sexual dimorphism, estrogen, testosterone  
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Testosterone-to-Estrogen Ratio is Associated with Female Facial Attractiveness 
Introduction 
Physical appearance plays an important role in mate choice for human as well as non-human 
animals, since attractiveness allegedly reflects biological quality. Much of the research on human 
mate preferences has focused on facial attractiveness (for reviews see Little, Jones, & DeBruine, 
2011). For human faces, at least four parameters influence facial attractiveness: symmetry, 
averageness, healthy appearance and sexual dimorphism (e.g., Little et al., 2011). In female faces 
sexually dimorphic characteristics include feminine features such as less prominent brow ridge 
and jaws, full lips and a small chin. Indeed, female faces with feminized traits are perceived as 
being more attractive than faces with average traits (Perrett et al., 1998; Rhodes, Hickford, & 
Jeffery, 2000). 
Feminine features become evident after the onset of puberty. During puberty the availability 
of endogenous sex hormones (such as testosterone, estrogens and progesterone) increases, 
affecting the development of secondary sexual features. Testosterone promotes the growth of 
lower face and jaw, cheekbones and brow ridges to more masculine features in men (Verdonck, 
Gaethofs, Carels, & de Zegher, 1999). In contrast, oestrogen is thought to be related to small 
bony features of the lower face, a flat middle face and large lips (Thornhill & Grammer, 1999), 
all of which are considered typically female traits. Faces of women with high estradiol levels 
should hence be particularly attractive (cf. Law-Smith et al., 2006). 
Johnston and Franklin (1993) hypothesized that testosterone in relation to oestrogen is 
responsible for the sexual dimorphism and that this ratio might be a reliable marker of female 
attractiveness: Females with low testosterone-to-oestrogen ratio may have the most attractive 
faces since masculinizing of facial features is prevented and instead lip size is increased, 
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resulting in a more feminine looking face (Enlow, 1990; Thornhill & Grammer, 1999). However, 
empirical evidence is scarce regarding the relation between female facial attractiveness and sex 
hormones. 
Virtually all studies that have investigated the relationship between female appearance and 
hormones measured only estradiol and progesterone (e.g., Jasienska, Ziomkiewicz, Ellison, 
Lipson, & Thune, 2004; Law-Smith et al., 2006; Puts et al., 2013). For example, Jasienska et al. 
(2004) investigated body characteristics such as breast size and waist-to-hip ratio (WHR) in 
relation to hormone levels and found that women with higher levels of trait estradiol have a more 
feminine body shape (large breasts, low WHR; but see Grillot, Simmons, Lukaszewski, & 
Roney, 2014). Law-Smith et al. (2006) compared concentrations of urinary oestrogen and 
progesterone metabolites with face ratings. Results showed that women with higher late 
follicular oestrogen levels have more feminine and more attractive looking faces than women 
with lower oestrogen levels. The authors conclude that oestrogen may be a marker for health and 
fertility. However they focused only on the female sex hormones and did not consider 
testosterone and its interaction effect with oestrogen. 
To our knowledge no previous study has looked at the influence of testosterone on female 
facial attractiveness. Testosterone is typically considered as the prototypical male sex hormone, 
while oestrogens and progesterone are considered as female sex hormones. Indeed, testosterone 
and oestrogens play a critical role in the respective sex-differentiation during neuro-development 
(Arnold & Gorski, 1984). As a result, virtually all studies that investigated the relationship 
between male facial appearance and hormones measured testosterone, while studies with females 
looked at oestrogens and progesterone. Yet, testosterone as well as oestrogens and progesterone 
are synthesized in both men and women. Hence, not only the availability of the respective sex 
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hormone, but in particular the right balance of hormones might be fundamental for the 
development and maintenance of physiological processes, for example in the regulation of body 
bone mass growth and maintenance (Callewaert, Boonen, & Vanderschueren, 2010; Oury & 
Nyas, 2012). 
The present work aims at assessing the relative role of testosterone, estradiol (a particular 
oestrogen that is found in humans) and the testosterone-to-estradiol (T/E) ratio on the shape of 
the attractive female face. Based on the reasoning mentioned above, we hypothesize that female 
facial attractiveness will be related to high levels of estradiol and low levels of testosterone. 
Specifically, we expect female faces with a lower T/E ratio to be perceived as more attractive 
than those with a higher T/E ratio. 
We experimentally mimicked the effect that these hormones have on female face shape 
using computer graphics software and asked participants to choose the faces they like best in a 
two alternative forced choice (2AFC) task. In Experiment 1 we separately compare attractiveness 
ratings of (i) faces of women with high levels of estradiol to faces of women with low estradiol 
levels, (ii) faces of women with high testosterone to faces of women with low testosterone levels, 
and (iii) faces of women with a high T/E ratio to faces of women with a low T/E ratio in order to 
establish whether the respective hormone levels and ratios are related to facial attractiveness. In 
Experiment 2 we established which of these hormonal markers is most strongly involved in 
female facial attractiveness.  
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EXPERIMENT 1 
Methods 
Stimuli 
Photography procedure 
Fifty-one naturally cycling Caucasian women aged between 19-34 years (M = 24.704, SD = 
3.965) were recruited for the following inclusion criteria: (a) no use of hormonal contraceptives 
for at least 3 previous months, (b) no suspected or confirmed pregnancy, (c) no breastfeeding, (d) 
regular menstrual cycle between 25 and 35 days of length, and (e) no medication. 
Each woman agreed to have her photograph and saliva sample taken twice, once during 
ovulation and once during the luteal phase. This was done to control for cyclic variations in 
hormone levels and facial appearance(Bobst & Lobmaier, 2012). The time of ovulation was 
determined using WH OvultellTM ovulation test strips, which measure the concentration of 
metabolite from luteinizing hormone (LH) in urine. The surge in LH provokes ovulation in the 
next 24-36 hours. This test is a valid assessment to determine the onset of ovulation (Miller & 
Soules, 1996). We used ovulation test strips rather than the backward-counting-method because 
the backward counting method has low validation (Wilcox, Dunson, & Baird, 2000) resulting 
from wide inter- and intra-individual variations concerning the onset of ovulation (Park, 
Goldsmith, Skurnick, Wojtczuk, & Weiss, 2007; Wilcox et al., 2000). Additionally, the 
backward-counting-method does not detect anovulatory cycles. For photographs taken during 
ovulation, women reported to the lab immediately after a positive ovulation test strip result and 
were photographed within 24 hours of the positive test result. The luteal phase photography 
session took place 7 days after the LH surge. Order of photography session was counter-balanced 
across women. Specifically, half of the women were scheduled to be photographed within 48 
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hours of LH surge and then again 7 days later. The other half of the women were scheduled to 
have their first photograph taken 7 days after the measured peak of the LH surge. These latter 
women then again assessed the LH surge in the following cycle and were then photographed for 
the second time within 48 hours of the next LH peak. In both phases pictures and saliva were 
taken at the same time of the day to control for circadian changes in hormone levels. All 
participants were photographed without wearing glasses and they were instructed to look directly 
into the camera with a neutral expression. Photographs were taken under standard conditions 
with lighting from six Philips TL-D 90 Graphica 18W 950 – 59 cm fluorescent lamps. The 
distance between the camera and participant was 2 m. Images were captured on a Nikon D90 
digital camera with a 50 mm lens and a resolution of 2163x3216 pixels. All women also 
completed the general health questionnaire (GHQ; Banks et al., 1980). 
Saliva samples were collected using commercially available sampling devices (Salivette; 
Sarstedt, Rommelsdorf, Germany and SaliCaps; IBL, Hamburg, Germany). Estradiol and 
testosterone concentrations were analyzed from the saliva samples by an independent laboratory 
(Dresden Lab Service GmbH, Dresden, Germany). For every individual woman, we averaged the 
levels of estradiol and testosterone concentrations of the two photography sessions from which 
we calculated the testosterone-to-estradiol ratios. Each of these hormone measures was rank-
ordered from the highest levels to the lowest levels. The 15 highest and lowest ranks of each 
respective hormone measure were used to create hormone level specific prototypes. Because 
saliva samples were collected using two different sampling devices (NSalivette = 23; NSalicaps = 28) 
and because they were analyzed in two separate batches, the absolute values of the hormone 
assays were not comparable. We hence z-transformed the values separately for each sampling 
device before rank-ordering the values. Importantly, the methodological procedure was identical 
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for both samples, the only difference being that we used different sampling devices (Salicaps and 
Salivette). 
Stimulus creation 
In a first step we created prototypes of high and low testosterone (T), estradiol (E) and T/E 
by averaging faces of 15 females with the highest and the 15 females with the lowest levels of T, 
E or T/E, respectively. The rationale here is that averaging a group of faces into one image 
reveals consistent characteristics of this group while characteristics that are not shared are 
averaged out. Using PsychoMorph computer graphics software (Tiddeman, Burt, & Perrett, 
2001), the shape of each face was manually defined with 178 facial landmark points, marking the 
shape and position of eyes and brows, nose, mouth, ears, cheekbones, chin, as well as the outer 
face shape (for a more detailed description of prototype creation see Tiddeman et al., 2001). We 
then averaged the face shapes with the highest and lowest levels of T, E or T/E. Note that the 
selection of faces that were included in the prototype was based on the average hormone levels 
of the two cycle phases; hence two photographs of each woman (one taken during ovulation and 
one taken during the luteal phase) were included in the prototype. T and E were not correlated (r 
= .085, p = .563) but T and T/E levels were generally highly correlated (r = .499, p < .001). 
Nevertheless, a relevant proportion of individual faces (40%) in the high T group differed from 
those in the high T/E group. The same applies to the low T versus the low T/E groups. 
Prototypes are shown in Figure 1a. 
Controlling for potential confounds 
Testosterone and estradiol levels underlie fluctuation during the day; they start out at high 
levels in the morning and then decline across the course of the day (Dabbs & Delarue, 1991; 
Goji, 1993). In order to ensure that creation of prototypes was not confounded with circadian 
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fluctuation or age, we run a regression analyses with hormonal levels as dependent variable and 
age, general health and time of testing as predictor variables. Separate analyses were done for T 
and E levels. We found no significant association between T levels and age, general health 
questionnaire and circadian fluctuation (all p’s > .105). The same pattern was found in E levels 
(all p’s > .372). Additional analysis showed that high and low hormone groups did not 
significantly differ in age (all p’s > .669). 
Stimulus Transformation 
In the second step, these prototypes were taken as the endpoints on a high-low hormone level 
continuum. We then mimicked the effects that these hormones have on facial shape by shape-
transforming unrelated faces towards the respective high and low prototypes. Sixty new frontal 
photographs of female Caucasian faces ranging in age between 18 and 35 years (M = 24.016, SD 
= 4.474) and showing a neutral expression were randomly selected from the CAL/PAL Face 
Database (Minear & Park, 2004). Twenty of these were shape-transformed towards the high and 
low estradiol prototypes, 20 were shape-transformed towards the high and low testosterone 
prototypes, and 20 towards the high and low T/E prototypes. Specifically, 75% of the linear 
differences in 2D shape between the high and low hormone prototype were added to face images 
of the new faces. Note that the transformation was shape transformation only, meaning that the 
stimuli differed only in shape while keeping other dimensions such as colour or luminance 
constant. This was done to avoid confounding effects due to different skin appearance (Stephen, 
Smith, Stirrat, & Perrett, 2009). The high and low versions of the same female face were paired 
and each pair was shown twice, once with the “high” face to the left, and once to the right. 
Faces were masked around the face line (for an example see Figure 1b). In total we used 3 
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(testosterone, estradiol, T/E) x 2 (lateralization on screen) x 20 (faces) = 120 face pairs in this 
experiment. 
Attractiveness Task and Participants 
Face pairs were randomly presented in two-alternative forced choice format on a computer 
screen. Participants were seated at a distance of 50 cm from a 17” monitor with a resolution of 
1280 x 1024 pixels on which face pairs appeared at a visual angle of approximately 11.42° x 8° 
and were asked to choose the more attractive female face. 
Fifty participants (29 female), ranging in age between 18 and 35 years (M = 24.54, SD = 3.81) 
took part in this study. For female participants we collected information about hormonal 
contraception use (21 contraceptive pill users, 8 naturally cycling) and menstrual cycle (length, 
onset of last menstruation, regularity). All participants provided written informed consent to take 
part in this study and were treated in accordance with the ethical protocol approved by local 
ethics committee and conformed with The Code of Ethics of the World Medical Association 
(Declaration of Helsinki). 
Statistical analysis 
Statistical analyses were performed using SPSS 22.0 with the significance level set at p = .05. 
According to our predictions, we coded answers as “correct” if participants chose the face that 
was transformed towards the prototype with the high E-level, low T-level and low T/E, 
respectively. A Shapiro-Wilk test showed that proportions of correctly chosen faces were normal 
distributed (p = .553). One-sample t-tests were used to test whether the proportion of correctly 
chosen faces significantly differ from chance (.50). Cohen’s d was used as a measure of effect 
size. Additionally, the proportion of correctly chose face was analyzed using repeated-measures 
ANOVA with hormone (T, E vs. T/E) as within-subject factor and participant sex (female vs. 
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male) as between subject factor. The Huynh-Feldt epsilon correction for heterogeneity of 
covariances (Huynh & Feldt, 1976) was used when sphericity could not be assumed. In the 
ANOVA partial eta squared (ηp2) was used a as measure of effect size. All post hoc pairwise 
comparisons were Bonferroni corrected. 
Results 
One-sample t-tests showed that for the T and T/E conditions the proportions of correctly chosen 
faces significantly differed from what would have been expected from chance (both t’s > 6.116, 
p’s < .001, d’s > 1.75). In the E condition, the percentage of trials in which the higher estradiol 
face was chosen as more attractive did not significantly differ from chance level, t(49) = -1.530, 
p = .132, d = -0.437. 
Repeated measures analysis of variance (ANOVA) showed a significant effect of hormone 
(F1.390, 66.746 = 22.728, p < .001, ηp2 = .321). Post-hoc pairwise comparisons revealed that the 
proportion of correctly chosen faces significantly differed between T and E (p < .001) and 
between T/E and E (p < .001), but no differed between T and T/E (p = .537). There was no effect 
of participants sex (F1, 48 =.618, p = .436, ηp2 =.013) and no participant sex x hormone interaction 
(F1.39, 66.75 = 2.322, p = .122, ηp2 =.046). Additional analyses revealed that for female participants 
hormonal contraception had no impact on the face preferences (p’s > .25). The results are shown 
in Figure 2. To investigate whether low T/E has a stronger impact on female attractiveness than 
low T, we conducted Experiment 2. 
EXPERIMENT 2 
The results of Experiment 1 indicate that faces of women with low testosterone levels are 
more attractive than faces of women with high testosterone levels. Likewise, faces of women 
with low testosterone-to-estradiol ratios were preferred over faces of women with high 
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testosterone-to estradiol ratios. This experimental design can not differentiate between 
preferences for facial cues associated with low testosterone levels and low testosterone-to-
estradiol ratios. Experiment 2 was designed to directly test the hypothesis that faces of women 
with a low testosterone-to-estradiol ratio are perceived as being more attractive than faces of 
women with low testosterone levels, as suggested by Johnston and Franklin (1993). 
Methods 
Stimuli and Attractiveness task 
The task and stimuli were very similar to Experiment 1, except that we shape-transformed 
faces between the low testosterone and low T/E prototypes. Specifically, a further twenty frontal 
photographs of Caucasian female faces ranging in age between 18 and 35 years (M = 24.45, SD 
= 5.041) and showing a neutral expression were randomly selected from the CAL/PAL Face 
Database (Minear & Park, 2004). In contrast to Experiment 1, faces were shape-transformed 
towards the low testosterone prototype and low testosterone-to-estradiol ratio prototype. In 
particular, 100% of the linear differences in 2D shape between the low T and low T/E hormone 
prototype were added to face images of the new faces. As in Experiment 1, the transformation 
was shape transformation only. We used 100% of difference in shape in Experiment 2 to enhance 
the differences between low testosterone and low testosterone-to-estradiol ratios. This was 
necessary because of the considerably large overlap between low T and low T/E faces. The low 
T and low T/E versions of the same female CAL/PAL face were paired and each pair was shown 
twice, counterbalancing the side on which each face appeared on the screen. Faces were masked 
around the face line in order to reduce peripheral cues such as clothes and hairdo. In total we 
used 2 (lateralization on screen) x 20 (faces) = 40 face pairs in this experiment. Participants were 
asked to choose the more attractive female face. 
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Participants 
Thirty-six students (22 females) aged between 19 and 42 years (M = 24.75, SD = 6.34) 
took part in this study for course credit. Similar to Experiment 1, for female participants, we 
collected information about hormonal contraception use (11 contraceptive pill users, 10 naturally 
cycling, 1 preferred not to report) and menstrual cycle (length, regularity and onset of last 
menstruation). All gave written informed consent. 
Results 
Answers were coded as correct if participants chose the face that was transformed towards the 
T/E prototype (according to our prediction). One-sample t-tests showed that low T/E faces were 
preferred over low T faces (M = 61.6 %, SD = 11.79 %, t(35) = 5.90, p < .001, d = 2.0). There 
was no effect of participant sex (t(34) = -.434, p = .667). Additionally, there was a tendency that 
naturally cycling women more often chose the low T/E face (M = 0.66, SD = 0.11) than women 
using hormonal contraception (M = 0.56, SD = 0.11; t(19) = -2.056, p = .054, d = -0.944). 
Discussion 
The aim of this study was to determine a possible hormonal marker for female facial 
attractiveness. We found that a low testosterone-to-estradiol ratio (T/E) seems to have a strong 
impact on female facial attractiveness, followed by low T levels. We found no influence of 
estradiol levels on facial attractiveness. 
The present study is the first to provide empirical evidence for an association between female 
facial attractiveness and the relation between circulating testosterone and estradiol levels (low 
T/high E) which was already suggested two decades ago (Johnston & Franklin, 1993). Low T/E 
ratio may inhibit masculinization of facial feature and instead might contribute to the increase of 
lip size, resulting in a more feminine appearance (Thornhill & Grammer, 1999). 
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Interestingly, faces with high E were not seen as more attractive than faces with low E when 
not controlling for T concentration. This is in contrast to previous findings reporting positive 
correlations between oestrogen levels and both attractiveness and femininity (Law-Smith et al., 
2006). By means of urinary oestrogen assays and facial photographs Law-Smith et al. (2006) 
investigated the relationship between circulating oestrogen, attractiveness and femininity. In 
contrast to our data, they found positive correlations between oestrogen levels and both 
attractiveness and femininity. There are two main differences that may account for this divergent 
result. First, Law-Smith et al. (2006) determined the oestrogen level in the late-follicular stage of 
the menstrual cycle. In our study we took the average of two cycle phases to cover the hormonal 
level of two distinct phases of the female cycle. More importantly, our stimuli were created by 
transforming only shape information, resulting in stimuli that differ only in shape but not in any 
other dimension, such as colour and luminance. Please note that the correlation between female 
attractiveness and oestrogen level was only present when the women did not wear make-up 
(Law-Smith et al., 2006). It is therefore plausible that the positive relation between oestrogen 
level and female attractiveness found by(Law-Smith et al., 2006) was mainly due to facial skin 
coloration and not to facial shape. Various researchers found that the rating of facial 
attractiveness is related to skin colour (Fink, Grammer, & Thornhill, 2001; Jones, Little, Burt, & 
Perrett, 2004; Stephen et al., 2009). At the same time endocrinological studies have shown that 
oestrogens have a protective influence on the skin thickness, wrinkling and moisture (Kanda & 
Watanabe, 2005; Sator, Schmidt, Sator, Huber, & Honigsmann, 2001; Verdier-Sevrain, Bonte, & 
Gilchrest, 2006). We suggest that estradiol levels may have a positive influence on attractiveness 
by making the skin appear healthier but are less responsible for the face shape.  
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An alternative explanation for why we found no effect of estradiol on facial shape may be 
that the body mass indexes (BMI) of the women might have obscured the relationship between 
estradiol and facial attractiveness. Indeed, a recent study by Grillot et al. (2014) found significant 
positive interaction between sex hormone levels and women’s body attractiveness only after 
controlling for BMI. Both of these speculative explanations do not detract from our main finding 
that the interaction between testosterone and estradiol (T/E ratio) plays a key role in shaping an 
attractive female face. 
Participant sex had no effect on the choice of the more attractive woman, indicating that men 
and women strongly agree on which females they find attractive. While this finding is consistent 
with previous literature (Penton-Voak & Chen, 2004), it must be taken with caution because of 
the relative low number of male raters (especially in Experime t 2). 
The present study shows a positive relationship between T/E and female attractiveness. The 
question remains why current sex hormone levels should be associated with female 
attractiveness, since sexually dimorphic traits mainly develop during puberty (e.g., Brook, 1981) 
and do not depend on momentary hormone levels. Given the assumption that levels of sex 
hormones remain relatively stable between puberty and menopause, current sex hormone levels 
can be seen as a proxy for pubertal hormone levels, mirroring the hormonal state of the critical 
pubertal period. Similar assumptions have been made in research looking at associations between 
hormone levels and facial appearance in men (e.g., Lefevre, Ewbank, Calder, von dem Hagen, & 
Perrett, 2013; Penton-Voak & Chen, 2004; Pound, Penton-Voak, & Surridge, 2009). Future 
directions should involve measuring the relationship between current female and male sex 
hormones during puberty. 
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We note that in the present study we focused only on shape information. Several studies 
suggest that other information, such as for example facial surface information (skin colour or 
texture) also influences perceptions of attractiveness (Fink et al., 2001; Lefevre et al., 2013). It 
seems that, particularly in women, both shape and surface information are relevant for an 
attractive appearance (Torrance, Wincenciak, Hahn, DeBruine, & Jones, 2014). It will be 
important to replicate these findings using other experimental approaches. Because some 
inconsistent findings in face preference have been found due to differences in the methods 
used to manipulate face images (see DeBruine, 2013; Scott, Clark, Boothroyd, & Penton-
Voak, 2012 for disscussion) it will be a necessary next step to test whether the effects found in 
this experimentally controlled paradigm survive in more ecologically valid, real-life settings 
where shape cues are confounded with colour and texture information (such as correlational 
studies using unmanipulated faces). A further limitation of the present study is that we did not 
control for BMI. Future studies are needed to clarify what effect BMI has on the association 
between sex hormones and facial appearance. 
In conclusion, we found that T/E is a valid hormonal maker for female attractiveness. We 
assume that adult hormone levels reflect hormone levels that were available during puberty, 
when important changes in facial appearance occur. The link between hormones and human 
facial features is a much-discussed topic in human evolutionary psychology, yet the relation 
between testosterone-to-estradiol ratio and facial appearance has not been quantified previously. 
We provide empirical evidence that an attractive female face has been shaped under the 
influence of optimally balanced androgenic and oestrogenic hormones. Our findings are in line 
with assumptions from evolutionary psychology stating that attractiveness is a reliable cue for 
women’s fertility and health. High estradiol levels accompanied by low testosterone levels (low 
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T/E ratio) are putatively valid signs of female fertility and faces that were shaped by particularly 
high estradiol/low testosterone levels hence appear to be especially attractive. Last but not least, 
our findings underline the importance to consider both androgenic and oestrogenic influences 
when studying female facial attractiveness. 
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Figure captions 
Figure 1. (a) Hormonal prototypes. Composite of 15 woman with lowest and highest levels of 
estradiol (E), composite of 15 woman with lowest and highest levels of testosterone (T), and 
composite of 15 woman with lowest and highest T/E ratios. (b) Example of a female face in the 
T/E condition. The face on the left is shape transformed to reduce T/E; the image on the right is a 
shape transformed to enhance T/E. 
Figure 2. Experiment 1: Proportion correct for estradiol transformation (E, white bar), 
testosterone (T, grey bar) and testosterone-to-estradiol ratio (T/E ratio, dark bar). Answers were 
coded as correct if participants chose the face that was transformed towards the prototype with 
the high E-level, low T-level and low T/E, respectively. Error bars depict standard errors (*** p 
< .001). 
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